Brokers Set Expectations for Organigram Q1 Earnings

Organigram Holdings Inc. (NASDAQ:OGI) – Analysts at Atb Cap Markets issued their Q1 2025 EPS estimates for shares of Organigram in a research report issued to clients and investors on Wednesday, December 18th. Atb Cap Markets analyst F. Gomes forecasts that the company will post earnings of ($0.02) per share for the quarter. The consensus estimate for Organigram’s current full-year earnings is ($0.20) per share. Atb Cap Markets also issued estimates for Organigram’s Q2 2025 earnings at ($0.03) EPS and FY2025 earnings at ($0.07) EPS.

Organigram (NASDAQ:OGI) last released its quarterly earnings results on Wednesday, December 18th. The company reported ($0.04) EPS for the quarter, missing the consensus estimate of ($0.03) by ($0.01). Organigram had a negative net margin of 45.57% and a negative return on equity of 16.76%.

Organigram Stock Performance

Organigram stock opened at $1.56 on Monday. Organigram has a fifty-two week low of $1.25 and a fifty-two week high of $2.91. The company has a market capitalization of $196.80 million, a price-to-earnings ratio of -3.71 and a beta of 1.02. The stock has a fifty day moving average of $1.61 and a two-hundred day moving average of $1.67.

Institutional Investors Weigh In On Organigram

A number of hedge funds and other institutional investors have recently modified their holdings of OGI. AdvisorShares Investments LLC boosted its position in Organigram by 11.8% during the second quarter. AdvisorShares Investments LLC now owns 1,000,126 shares of the company’s stock worth $1,540,000 after acquiring an additional 105,468 shares during the last quarter. Renaissance Technologies LLC lifted its stake in shares of Organigram by 40.8% during the 2nd quarter. Renaissance Technologies LLC now owns 816,948 shares of the company’s stock worth $1,258,000 after purchasing an additional 236,700 shares during the period. Toronto Dominion Bank boosted its holdings in shares of Organigram by 803.7% during the third quarter. Toronto Dominion Bank now owns 16,727 shares of the company’s stock worth $30,000 after purchasing an additional 14,876 shares during the last quarter. Finally, Tidal Investments LLC boosted its holdings in shares of Organigram by 8.3% during the third quarter. Tidal Investments LLC now owns 1,948,188 shares of the company’s stock worth $3,526,000 after purchasing an additional 149,171 shares during the last quarter. 34.63% of the stock is currently owned by hedge funds and other institutional investors.

Organigram Company Profile

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.